Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey‐Holden Prostate Cancer Academy Meeting (English)
- New search for: Miyahira, Andrea K.
- New search for: Cheng, Heather H.
- New search for: Abida, Wassim
- New search for: Ellis, Leigh
- New search for: Harshman, Lauren C.
- New search for: Spratt, Daniel E.
- New search for: Simons, Jonathan W.
- New search for: Pienta, Kenneth J.
- New search for: Soule, Howard R.
- New search for: Miyahira, Andrea K.
- New search for: Cheng, Heather H.
- New search for: Abida, Wassim
- New search for: Ellis, Leigh
- New search for: Harshman, Lauren C.
- New search for: Spratt, Daniel E.
- New search for: Simons, Jonathan W.
- New search for: Pienta, Kenneth J.
- New search for: Soule, Howard R.
In:
The Prostate
;
77
, 15
;
1478-1488
;
2017
- Article (Journal) / Electronic Resource
-
Title:Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey‐Holden Prostate Cancer Academy Meeting
-
Contributors:Miyahira, Andrea K. ( author ) / Cheng, Heather H. ( author ) / Abida, Wassim ( author ) / Ellis, Leigh ( author ) / Harshman, Lauren C. ( author ) / Spratt, Daniel E. ( author ) / Simons, Jonathan W. ( author ) / Pienta, Kenneth J. ( author ) / Soule, Howard R. ( author )
-
Published in:The Prostate ; 77, 15 ; 1478-1488
-
Publisher:
-
Publication date:2017-11-01
-
Size:11 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 77, Issue 15
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1451
-
Issue Information ‐ Editorial Board| 2017
- 1452
-
The protein kinase C super‐family member PKN is regulated by mTOR and influences differentiation during prostate cancer progressionYang, Chun‐Song / Melhuish, Tiffany A. / Spencer, Adam / Ni, Li / Hao, Yi / Jividen, Kasey / Harris, Thurl E. / Snow, Chelsi / Frierson, Henry F. Jr. / Wotton, David et al. | 2017
- 1468
-
Reduced number of CD169+ macrophages in pre‐metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patientsStrömvall, Kerstin / Sundkvist, Kristoffer / Ljungberg, Börje / Halin Bergström, Sofia / Bergh, Anders et al. | 2017
- 1478
-
Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey‐Holden Prostate Cancer Academy MeetingMiyahira, Andrea K. / Cheng, Heather H. / Abida, Wassim / Ellis, Leigh / Harshman, Lauren C. / Spratt, Daniel E. / Simons, Jonathan W. / Pienta, Kenneth J. / Soule, Howard R. et al. | 2017
- 1489
-
Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up‐regulation of IRF1Kanayama, Mayuko / Hayano, Toshiya / Koebis, Michinori / Maeda, Tatsuya / Tabe, Yoko / Horie, Shigeo / Aiba, Atsu et al. | 2017
- 1499
-
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancerPedraza‐Arévalo, Sergio / Hormaechea‐Agulla, Daniel / Gómez‐Gómez, Enrique / Requena, María J. / Selth, Luke A. / Gahete, Manuel D. / Castaño, Justo P. / Luque, Raul M. et al. | 2017
- 1512
-
Sexual steroids in serum and prostatic tissue of human non‐cancerous prostate (STERPROSER trial)Neuzillet, Yann / Raynaud, Jean‐Pierre / Radulescu, Camélia / Fiet, Jean / Giton, Franck / Dreyfus, Jean‐François / Ghoneim, Tarek P. / Lebret, Thierry / Botto, Henry et al. | 2017
- 1520
-
Impact of five‐tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high‐dose‐rate brachytherapyTsumura, Hideyasu / Ishiyama, Hiromichi / Tabata, Ken‐ichi / Katsumata, Hiroki / Kobayashi, Momoko / Ikeda, Masaomi / Kurosaka, Shinji / Fujita, Tetsuo / Kitano, Masashi / Satoh, Takefumi et al. | 2017
- 1528
-
High‐Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerBurdelski, Christoph / Shihada, Rami / Hinsch, Andrea / Angerer, Alexander / Göbel, Cosima / Friedrich, Emily / Hube‐Magg, Claudia / Burdak‐Rothkamm, Susanne / Kluth, Martina / Simon, Ronald et al. | 2017
- 1539
-
The unidirectional hypoxia‐activated prodrug OCT1002 inhibits growth and vascular development in castrate‐resistant prostate tumorsNesbitt, Heather / Worthington, Jenny / Errington, Rachel J. / Patterson, Laurence H. / Smith, Paul J. / McKeown, Stephanie R. / McKenna, Declan J. et al. | 2017